SONN Sonnet BioTherapeutic

Watchlist

Close Apr 26 16:00 ET

Post 17:07 ET

5.43MMarket Cap-2132P/E (TTM)

Sonnet BioTherapeutic Stock Analyst Ratings & Price Target

Updated: Mar 31, 2024

Based on 2 analysts giving stock ratings to Sonnet BioTherapeutic in the past 3 months

Buy

Updated: Mar 31, 2024

The average Sonnet BioTherapeutic stock price target is 16.00 with a max estimate of 30.00 and a min estimate of 2.00

Review Sonnet BioTherapeutic earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Mar 31, 2024

Buy

Updated: Mar 31, 2024

Overall